Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Human Growth Hormone Market, by Application
1.4.2 Asia Pacific Growth Hormone Deficiency Market, by Type
1.4.3 Asia Pacific Human Growth Hormone Market, by Distribution Channel
1.4.4 Asia Pacific Human Growth Hormone Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Asia Pacific Human Growth Hormone Market by Application
3.1 Asia Pacific Small for Gestational Age Market by Country
3.2 Asia Pacific Prader-Willi Syndrome Market by Country
3.3 Asia Pacific Idiopathic Short Stature Market by Country
3.4 Asia Pacific Turner Syndrome Market by Country
3.5 Asia Pacific Growth Hormone Deficiency Market by Country
3.5.1 Asia Pacific Growth Hormone Deficiency Application Market by Type
3.5.1.1 Asia Pacific Pediatric Growth Hormone Deficiency Market by Country
3.5.1.2 Asia Pacific Adult Growth Hormone Deficiency Market by Country
3.6 Asia Pacific Other Applications Market by Country
Chapter 4. Asia Pacific Human Growth Hormone Market by Distribution Channel
4.1 Asia Pacific Retail Pharmacy Market by Country
4.2 Asia Pacific Hospital Pharmacy Market by Country
4.3 Asia Pacific Specialty Pharmacy Market by Country
4.4 Asia Pacific Online Pharmacy Market by Country
Chapter 5. Asia Pacific Human Growth Hormone Market by Country
5.1 China Human Growth Hormone Market
5.1.1 China Human Growth Hormone Market by Application
5.1.1.1 China Growth Hormone Deficiency Application Market by Type
5.1.2 China Human Growth Hormone Market by Distribution Channel
5.2 Japan Human Growth Hormone Market
5.2.1 Japan Human Growth Hormone Market by Application
5.2.1.1 Japan Growth Hormone Deficiency Application Market by Type
5.2.2 Japan Human Growth Hormone Market by Distribution Channel
5.3 India Human Growth Hormone Market
5.3.1 India Human Growth Hormone Market by Application
5.3.1.1 India Growth Hormone Deficiency Application Market by Type
5.3.2 India Human Growth Hormone Market by Distribution Channel
5.4 South Korea Human Growth Hormone Market
5.4.1 South Korea Human Growth Hormone Market by Application
5.4.1.1 South Korea Growth Hormone Deficiency Application Market by Type
5.4.2 South Korea Human Growth Hormone Market by Distribution Channel
5.5 Singapore Human Growth Hormone Market
5.5.1 Singapore Human Growth Hormone Market by Application
5.5.1.1 Singapore Growth Hormone Deficiency Application Market by Type
5.5.1.1.1 Singapore Human Growth Hormone Market by Distribution Channel
5.6 Malaysia Human Growth Hormone Market
5.6.1 Malaysia Human Growth Hormone Market by Application
5.6.1.1 Malaysia Growth Hormone Deficiency Application Market by Type
5.6.2 Malaysia Human Growth Hormone Market by Distribution Channel
5.7 Rest of Asia Pacific Human Growth Hormone Market
5.7.1 Rest of Asia Pacific Human Growth Hormone Market by Application
5.7.1.1 Rest of Asia Pacific Growth Hormone Deficiency Application Market by Type
5.7.2 Rest of Asia Pacific Human Growth Hormone Market by Distribution Channel
Chapter 6. Company Profiles
6.1 Merck Group
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Segmental and Regional Analysis
6.1.4 Research & Development Expense
6.1.5 Recent strategies and developments:
6.1.5.1 Geographical Expansions:
6.2 Teva Pharmaceutical Industries Ltd.
6.2.1 Company Overview
6.2.2 Financial Analysis
6.2.3 Regional Analysis
6.2.4 Research & Development Expenses
6.2.5 Recent strategies and developments:
6.2.5.1 Product Launches and Product Expansions:
6.3 Ipsen Pharma Biotech SAS
6.3.1 Company Overview
6.3.2 Financial Analysis
6.3.3 Segmental and Regional Analysis
6.3.4 Research & Development Expense
6.3.5 Recent strategies and developments:
6.3.5.1 Partnerships, Collaborations, and Agreements:
6.3.5.2 Product Launches and Product Expansions:
6.3.5.3 Approvals:
6.4 Novartis AG (Sandoz International GmbH)
6.4.1 Company Overview
6.4.2 Financial Analysis
6.4.3 Segmental and Regional Analysis
6.4.4 Research & Development Expense
6.4.5 Recent strategies and developments:
6.4.5.1 Partnerships, Collaboration, and Agreements:
6.4.5.2 Product Launches and Product Expansions:
6.5 Pfizer, Inc.
6.5.1 Company Overview
6.5.2 Financial Analysis
6.5.3 Segmental and Regional Analysis
6.5.4 Research & Development Expense
6.6 F. Hoffmann-La Roche Ltd. (Genentech, Inc.)
6.6.1 Company Overview
6.6.2 Financial Analysis
6.6.3 Segmental and Regional Analysis
6.6.4 Research & Development Expense
6.7 Ferring Holdings SA
6.7.1 Company Overview
6.7.2 Financial Analysis
6.7.3 Research & Development Expenses
6.8 Novo Nordisk A/S
6.8.1 Company Overview
6.8.2 Financial Analysis
6.8.3 Segmental & Regional Analysis
6.8.4 Research & Development Expenses
6.9 Eli Lilly and Company
6.9.1 Company Overview
6.9.2 Financial Analysis
6.9.3 Regional Analysis
6.9.4 Research & Development Expense
6.1 Anhui Anke Biotechnology Group Co., Ltd.
6.10.1 Company Overview
Unique Offerings 